RNS Number:6723Q
ReGen Therapeutics PLC
08 October 2003

ReGen Therapeutics Plc

8 October 2003

SUBSTANTIAL SHAREHOLDING

ReGen Therapeutics Plc (the "Company") announces that on 8 October 2003 it
received notification from Mr P. Garrod that he is beneficially interested in
24,000,000 ordinary shares of the Company representing 10.69% of the current
issued share capital of the Company.


For further information, please contact:

Andrew Marshall
Marshall Robinson Roe
Tel. 020 7960 6007


                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLEALEPESLDFFE